Document is current
Any future updates will be listed below
-
Authors
Larson, Rebecca C.
Kann, Michael C.
Bailey, Stefanie R. https://orcid.org/0000-0002-1175-521X
Haradhvala, Nicholas J. https://orcid.org/0000-0003-1113-3135
Llopis, Paula Montero https://orcid.org/0000-0002-5983-2296
Bouffard, Amanda A.
Scarfó, Irene
Leick, Mark B.
Grauwet, Korneel
Berger, Trisha R.
Stewart, Kai
Anekal, Praju Vikas
Jan, Max
Joung, Julia
Schmidts, Andrea https://orcid.org/0000-0001-7035-1584
Ouspenskaia, Tamara https://orcid.org/0000-0002-5462-7103
Law, Travis https://orcid.org/0000-0002-7399-3299
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Getz, Gad
Maus, Marcela V. https://orcid.org/0000-0002-7578-0393
- License Information
-
More Information
Article History
Received: 1 June 2021
Accepted: 25 February 2022
First Online: 13 April 2022
Competing interests
: N.J.H. is a consultant for Constellation Pharmaceuticals. I.S. is now an employee of Arsenal Bio. T.O. is an employee of Flagship Labs 69, Inc. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and until 31 August 2020 was a member of the scientific advisory boards of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and ThermoFisher Scientific. From 1 August 2020, A.R. has been an employee of Genentech, a member of the Roche Group. G.G. receives research funds from IBM and Pharmacyclics, and is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect, MSMutSig, MSIDetect, POLYSOLVER and TensorQT. G.G. is a founder, consultant and holds privately held equity in Scorpion Therapeutics. M.V.M. receives sponsored research support from KitePharma and Novartis. M.V.M. is an inventor on patents related to adoptive cell therapies held by Massachusetts General Hospital and University of Pennsylvania (some licensed to Novartis). M.V.M. holds equity in 2Seventy Bio, TCR2, Century Therapeutics, Genocea, Oncternal and Neximmune, and has served as a consultant for multiple companies involved in cell therapies. M.V.M. serves on the Board of Directors of 2Seventy Bio. The other authors declare no competing interests.
